The Board authorizes the District’s Chief Medical Director to issue a non-patient specific order to school nurses to administer intranasal naloxone (also known as Narcan, among other names) or the least invasive method of administration available. The non-patient specific order shall include a written protocol containing the elements required by the regulations of the Commissioner of Education. The Board permits school nurses to administer naloxone to any person at school or a school event displaying symptoms of an opioid overdose. The District shall provide the naloxone kits to be stored in the nurse’s office. Naloxone shall be accessible during school hours and during on-site school-sponsored activities when the nurse is present.
The Chief Medical Director shall collaborate with school nurses to develop procedures for the placement, storage, inventory, re-ordering, administration documentation, reporting, and training of the school nurse, regarding the use of naloxone.
There will be at least one naloxone kit per building. The school nurse shall maintain a log of naloxone supplies as required.
School nurses shall follow the non-patient specific order and written protocol for administration of naloxone, which includes criteria for assessment and directions for administration. School nurses shall document all administration of naloxone in the same manner as the administration of other medications under non-patient specific orders. School nurses shall report all administration of naloxone to the Chief Medical Director, Principal and Superintendent.
If there is a patient-specific order for a particular student, the District will follow the guidance in the current New York State Education Department Guidelines for Medication Management in Schools, as appropriate.
Naloxone will be stored in secure, but accessible, locations consistent with the District’s emergency response plan, which may include AED cabinets. Such locations will be designed to provide ready and appropriate access for use during emergencies.
The District will ensure that there is at least one backup naloxone kit for each kit that is ready to be used, and another backup kit will be ordered when a naloxone kit is used. Naloxone that is nearing its expiration date will be replaced. The school nurse will maintain a log of naloxone supplies containing the following information: lot number, date of receipt, expiration date, and location. The school nurse will perform an inventory check of naloxone supplies at least monthly.
The use of naloxone will be documented in the individual’s cumulative health record for students, or consistent with applicable policies for care administered to staff. Documentation must include the date and time, and route of administration noting the anatomical location if intramuscular was administered; the signs and symptoms displayed by the student or staff member prior to administration; the student or staff member’s response to naloxone administration, if CPR/rescue breathing/AED was administered; the name of the EMS agency providing transport, along with the name of the health care facility the student/staff person was transported to; and signed by the person completing the documentation. Incident reports will be completed as per District policy.
This policy and any related procedures will be reviewed annually to ensure they continue to meet the needs of the District and are consistent with recommended best practice.
Cross-ref: 5420, Student Health Services
Ref: Education Law §§922 (volunteer naloxone responder); 6527 (emergency treatment of anaphylaxis and opioid overdose); 3023 (liability coverage); 6909 (administration of naloxone by nurses)
Public Health Law §3309 (volunteer naloxone responder)
8 NYCRR §§ 64.7 (administration of naloxone); Part 136 (school health services program, including naloxone)
10 NYCRR §80.138 (volunteer naloxone responder)
Guidance for Implementing Opioid Overdose Prevention Measures in Schools, New York State Education Department, 8/11/15,
Opioid Overdose Prevention: Guidelines for Policies and Procedures, New York State Department of Health, March 2014,
Adoption date: January 23, 2023